Navigation Links
AllCells Introduces Autoimmune Diseased Cells and Tissue Products
Date:9/11/2012

EMERYVILLE, Calif., Sept. 11, 2012 /PRNewswire/ -- AllCells, LLC, a leading provider of healthy & diseased hematopoietic tissues, primary cell types, and related services to the global life science industry has announced the release of new autoimmune diseased cells and tissue products. The specimens may be used in preclinical research, drug discovery, drug toxicity, diagnostic related assays, and other life science research applications. All products are indicated for in vitro research use only.

"The introduction of this autoimmune product line fulfills a vital need by our customers to obtain hematologic samples from a variety of autoimmune indications. These products serve as essential components of cell-based assays commonly used in the work-flow of our customers' preclinical research projects," commented Eric Martinelli, Business Development Manager.  

AllCells provides peripheral blood and/or isolated cell types from patients diagnosed with Autoimmune diseases such as  Rheumatoid Arthritis, Osteoarthritis, Systemic Lupus Erythematosus (SLE), Psoriasis, Type I & Type II Diabetes, and Multiple Sclerosis. Autoimmune plasma and peripheral blood mononuclear cells are available from each disease type.

Patient treatment history and clinical reports are available for each sample, and may include auto antibody analysis and/or clinical diagnostic scores (ACR, SLEDAI, etc.). Autoimmune Diseased Cells & Tissue products are obtained from volunteers participating in an Institutional Review Board (IRB) or Human Subject Committee approved donor program. All donors sign an informed consent form, and are screened for infectious diseases (HIV, Hepatitis B & C).

For more information about autoimmune diseased cells and tissue specimens, visit www.AllCells.com.

Full release available here:  http://www.allcells.com/blog/allcells-introduces-autoimmune-diseased-cells-and-tissue-products/.    

About AllCells, LLC
AllCells, LLC is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.


'/>"/>
SOURCE AllCells, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. AllCells, LLC Named to Inc. Magazines 500/5000 List of Fastest Growing Companies
2. Vision Research Introduces the Newest Member Of the Phantom®- 1Mpx- v-Series Camera Family
3. JPSA Introduces Picosecond Laser Micromachining System
4. Profit Lifter for Pro Mold Removers: Molderizer Introduces Remediation Product Like No Other
5. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
6. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
7. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
8. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
9. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
10. Genalyte Launches Maverick ENA Kits For Fast, Easy And Accurate Multiplexed Autoimmune Testing
11. Stem Cells Bring New Hope for Parry-Romberg Syndrome Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June 23, 2016 Houston Methodist ... the Cy-Fair Sports Association to serve as their ... agreement, Houston Methodist Willowbrook will provide sponsorship support, ... connectivity with association coaches, volunteers, athletes and families. ... the Cy-Fair Sports Association and to bring Houston ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
(Date:3/22/2016)... , March 22, 2016 ... research report "Electronic Sensors Market for Consumer Industry by ... & Others), Application (Communication & IT, Entertainment, ... - Global Forecast to 2022", published by ... is expected to reach USD 26.76 Billion ...
Breaking Biology News(10 mins):